76632-20-7 Usage
Uses
Used in Pharmaceutical Research and Development:
ISOXAZOLE, 3-(BROMOMETHYL)is used as a key intermediate in the synthesis of pharmaceutical compounds for various therapeutic applications. Its unique structure and reactivity enable the creation of new drug candidates with potential medicinal properties.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, ISOXAZOLE, 3-(BROMOMETHYL)serves as a building block for the design and synthesis of novel bioactive molecules. Its incorporation into molecular structures can lead to the development of compounds with improved pharmacological profiles, such as enhanced potency, selectivity, and reduced side effects.
Used in Agrochemical Development:
ISOXAZOLE, 3-(BROMOMETHYL)is also utilized in the agrochemical industry for the synthesis of new pesticides and other crop protection agents. Its chemical properties allow for the development of compounds with effective pest control capabilities and reduced environmental impact.
Used in Chemical Synthesis:
ISOXAZOLE, 3-(BROMOMETHYL)is employed as a versatile reagent in various chemical synthesis processes. Its ability to undergo a range of reactions makes it suitable for the preparation of diverse organic compounds for use in different industries, including the production of specialty chemicals, materials, and intermediates for further reactions.
Check Digit Verification of cas no
The CAS Registry Mumber 76632-20-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,6,6,3 and 2 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 76632-20:
(7*7)+(6*6)+(5*6)+(4*3)+(3*2)+(2*2)+(1*0)=137
137 % 10 = 7
So 76632-20-7 is a valid CAS Registry Number.
76632-20-7Relevant academic research and scientific papers
AMINE COMPOUND FOR INHIBITING SSAO / VAP-1 AND USE THEREOF
-
Paragraph 0282; 0287; 0635-0637, (2020/12/13)
An amine compound serving as a semicarbazide-sensitive amine oxidase (SSAO) and/or vascular adhesion protein-1 (VAP-1) inhibitor, a pharmaceutical composition, and an application thereof in medicines that can be used for treating inflammation and/or inflammation related diseases, diabetes and/or a disease related diabetes, psychiatric disorder, ischemic disease, vascular disease, fibrosis, or tissue transplant rejection.
THAILANSTATIN ANALOGS
-
Paragraph 0373; 0375, (2019/04/05)
The invention provides novel cytotoxic compounds and cytotoxic conjugates comprising these cytotoxic compounds and cell-binding agents. More specifically, this invention relates to novel thailanstatin A analogs, useful as cytotoxic small molecule toxins i
BENZIMIDAZOLE DERIVATIVES AS SELECTIVE ACID PUMP INHIBITORS
-
Page/Page column 47, (2008/06/13)
Abstract This invention relates to compounds of the formula (I): or a pharmaceutically acceptable salt thereof, wherein: R1, R2, R3, R4, A and E are each as described herein or a pharmaceutically acceptable salt